Clinical Trials in Washington

Showing 9101-9120 of 9,462 trials

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

NCT01055847

This is multicenter placebo-controlled study evaluating the safety and efficacy of AI at two dosage levels compared to placebo in CF patients with P. aeruginosa lung infection.

Cystic FibrosisCFLung Infection+1 more

Gilead Sciences105 participantsStarted Jun 2003

Los Angeles, California, United States • Orange, California, United States • San Diego, California, United States +17 more locations

COMPLETEDPhase 242 miles

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

NCT00202982

This is a study to test if a new higher dose of Copaxone is more effective in treating relapsing-remitting multiple sclerosis than the currently available 20 mg dose.

Relapse-Remitting Multiple Sclerosis

Teva Branded Pharmaceutical Products R&D, Inc.90 participantsStarted Aug 2003

La Jolla, California, United States • Oceanside, California, United States • Atlanta, Georgia, United States +17 more locations

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Find Trials by Condition in Washington

North American Study for the Treatment of Refractory Ascites (NASTRA)

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Memory Impairment Study (Mild Cognitive Impairment Study)

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Starting Healthy Staying Healthy Pilot Trial

Marketing Workplace Chronic Disease Prevention

Study of Paraesophageal Hernia Repair With Small Intestine Submucosa

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma